2022 was a year for celebration for BioCrossroads, not only because the life sciences sector continued strong growth and success, but because it was the organization’s 20th anniversary which marked a time to not only reflect on past accomplishments and achievements, but to also look forward to the future of the industry and the next generation of talent.
MASSIVE MARKET KNOWLEDGE
BioCrossroads undertook an ambitious year of coordinating and releasing capital and economic impact reports; profiles of innovators and change makers; and tracking the organization’s two decades of work – publishing ten reports in all.
To honor the next generation of life sciences leaders, BioCrossroads developed the 23 PAIR (Promising Achievers in Innovation and Research) recognition program in 2022.
ENGAGING THROUGH EVENTS
With more than 100 events developed and hosted over the last two decades, BioCrossroads took advantage of the celebratory year to put a spin on their annual Indiana Life Sciences Summit and created a CELLebration event which highlighted the impact and importance of Indiana’s life sciences industry on the people who benefit from their innovations. In addition, the organization held six FrameWORX events.
DIVING INTO THE DATA
The AnalytiXIN Health Data Asset, which is managed by BioCrossroads, made substantial progress in 2022 to provide de-identified, linked, clinical-genomic data to industry and academic researchers.
ECONOMIC IMPACT IN INDIANA
The annual report also outlines the economic impact of the life sciences sector in Indiana.